1 |
HeartMate 3
(97 times)
|
Cardiology (54 times)
|
LVAD (36 times) HMII (22 times) LVADs (14 times)
|
2016 Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility.
|
2 |
HeartMate 3 left ventricular assist device
(2 times)
|
Transplantation (1 time)
|
BSA (1 time) ESHF (1 time) ICU (1 time)
|
2017 Short-term Results of Heartmate 3 Ventricular Assist Device Implantation for End-Stage Heart Failure.
|
3 |
Henderson's Method 3
(2 times)
|
Genetics (2 times)
|
REML (2 times) MINQUE (1 time) MIVQUE (1 time)
|
1994 Variance component estimation techniques compared for two mating designs with forest genetic architecture through computer simulation.
|
4 |
alpha,alpha'-dihydro-3',4,5'-trihydroxy-4'-methoxy-2',3-diisopentenylstilbene
(1 time)
|
Physiology (1 time)
|
HM2 (1 time) RCT (1 time)
|
2018 Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity.
|
5 |
HM3 and Lithostar
(1 time)
|
Urology (1 time)
|
ESWL (1 time)
|
1989 [Second generation shock wave lithotripsy: experience with the Siemens Lithostar].
|
6 |
HM3 arm costs were 51% lower than with the HMII
(1 time)
|
Cardiology (1 time)
|
HMII (1 time)
|
2018 Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
|
7 |
HM3 arm experienced fewer total hospitalizations per patient-year
(1 time)
|
Cardiology (1 time)
|
HMII (1 time)
|
2018 Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
|
8 |
HM3 group
(1 time)
|
Cardiology (1 time)
|
HMII (1 time)
|
2018 Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
|
9 |
HM3 lithotripter
(1 time)
|
Urology (1 time)
|
ESWL (1 time)
|
2011 A prospective randomised trial comparing the modified HM3 with the MODULITH SLX-F2 lithotripter.
|
10 |
HM3 lithotripter led to fewer secondary treatments
(1 time)
|
Urology (1 time)
|
ESWL (1 time)
|
2011 A prospective randomised trial comparing the modified HM3 with the MODULITH SLX-F2 lithotripter.
|
11 |
HM3 lithotripter's stone-free rate was higher at 3 mo
(1 time)
|
Urology (1 time)
|
ESWL (1 time)
|
2011 A prospective randomised trial comparing the modified HM3 with the MODULITH SLX-F2 lithotripter.
|